TipRanks Black Friday Sale
- Claim 60% off TipRanks Premium for the data-backed insights and research tools you need to invest with confidence.
- Subscribe to TipRanks' Smart Investor Picks and see our data in action through our high-performing model portfolio - now also 60% off
An update from Suven Pharmaceuticals Ltd. ( (IN:SUVENPHAR) ) is now available.
Suven Pharmaceuticals Ltd has announced a revised schedule for their conference call to discuss the unaudited financial results for the third quarter and nine months of the fiscal year 2025. The call, which will include key members of the management team, is set to take place on February 12, 2025. This conference call is an important event for investors and stakeholders, as it will provide insights into the company’s financial performance and strategic direction.
More about Suven Pharmaceuticals Ltd.
Suven Pharmaceuticals Ltd is a prominent player in the pharmaceutical industry, focusing on the development and manufacturing of active pharmaceutical ingredients and intermediates. The company is headquartered in Mumbai and Hyderabad, India, and is known for its commitment to innovation and quality in the pharmaceutical sector.
YTD Price Performance: 2.78%
Average Trading Volume: 9,305
Current Market Cap: 294.1B INR
Learn more about SUVENPHAR stock on TipRanks’ Stock Analysis page.